GeoVax Labs Statistics

Total Valuation

GeoVax Labs has a market cap or net worth of $4.60 million. The enterprise value is $3.83 million.

Market Cap	4.60M
Enterprise Value	3.83M

Important Dates

The last earnings date was Tuesday, May 14, 2024, after market close.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

GeoVax Labs has 2.53 million shares outstanding. The number of shares has increased by 34.81% in one year.

Shares Outstanding	2.53M
Shares Change (YoY)	+34.81%
Shares Change (QoQ)	+19.51%
Owned by Insiders (%)	1.45%
Owned by Institutions (%)	9.52%
Float	2.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	84.78
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87, with zero debt.

Current Ratio	0.87
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -346.20% and return on invested capital (ROIC) is -52,243.95%.

Return on Equity (ROE)	-346.20%
Return on Assets (ROA)	-221.80%
Return on Capital (ROIC)	-52,243.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.63M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.43% in the last 52 weeks. The beta is 2.93, so GeoVax Labs's price volatility has been higher than the market average.

Beta (1Y)	2.93
52-Week Price Change	-80.43%
50-Day Moving Average	1.70
200-Day Moving Average	4.85
Relative Strength Index (RSI)	56.45
Average Volume (30 Days)	57,004

Short Selling Information

The latest short interest is 21,347, so 0.84% of the outstanding shares have been sold short.

Short Interest	21,347
Short Previous Month	7,291
Short % of Shares Out	0.84%
Short % of Float	0.94%
Short Ratio (days to cover)	0.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.36M
Pretax Income	-27.78M
Net Income	-27.78M
EBITDA	-27.70M
EBIT	-27.78M
Earnings Per Share (EPS)	-$14.51

Full Income Statement

Balance Sheet

The company has $768,859 in cash and no debt, giving a net cash position of $768,859 or $0.30 per share.

Cash & Cash Equivalents	768,859
Total Debt	n/a
Net Cash	768,859
Net Cash Per Share	$0.30
Equity / Book Value	54,275
Book Value Per Share	0.02
Working Capital	-441,529

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.09 million and capital expenditures -$48,946, giving a free cash flow of -$27.14 million.

Operating Cash Flow	-27.09M
Capital Expenditures	-48,946
Free Cash Flow	-27.14M
FCF Per Share	-$11.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GeoVax Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.81%
Shareholder Yield	-34.81%
Earnings Yield	-603.69%
FCF Yield	-589.88%

Analyst Forecast

The average price target for GeoVax Labs is $120.00, which is 6,493.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$120.00
Price Target Difference	6,493.41%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 31, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Jan 31, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1